Literature DB >> 17380064

Surgery for diabetic retinopathy.

Horst Helbig1.   

Abstract

Surgery for diabetic retinopathy addresses late secondary complications of a primary microvascular disease. Since surgery is not a causative therapy, the functional outcome of surgery depends on the degree of retinal ischemia and may be disappointing even in technically and anatomically successfully operated eyes. Typical indications for vitrectomy are vitreous hemorrhage, tractional retinal detachment, combined tractional rhegmatogenous retinal detachment and tractive macular edema. More recently diffuse diabetic macular edema has been shown to improve after removal of an attached vitreous in several cases. Neovascular glaucoma requires aggressive surgical intervention to salvage the eye. Cataract surgery is commonly performed in eyes with diabetic retinopathy. It may however deteriorate diabetic eye disease. Vitreous surgery also has a potential for severe complications in diabetic eyes which can be ameliorated but not eliminated by proper surgical strategies and techniques. The decision for an intervention in diabetic eyes always requires a careful weighing of risks and benefits of surgery. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17380064     DOI: 10.1159/000098255

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  7 in total

Review 1.  Diabetic complications in the cornea.

Authors:  Alexander V Ljubimov
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

Review 2.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

3.  Enhanced wound healing, kinase and stem cell marker expression in diabetic organ-cultured human corneas upon MMP-10 and cathepsin F gene silencing.

Authors:  Mehrnoosh Saghizadeh; Irina Epifantseva; David M Hemmati; Chantelle A Ghiam; William J Brunken; Alexander V Ljubimov
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-17       Impact factor: 4.799

4.  Normalization of wound healing and stem cell marker patterns in organ-cultured human diabetic corneas by gene therapy of limbal cells.

Authors:  Mehrnoosh Saghizadeh; Christian M Dib; William J Brunken; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2014-10-30       Impact factor: 3.467

5.  Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy.

Authors:  Lei Shi; Yi-Fei Huang
Journal:  J Res Med Sci       Date:  2012-09       Impact factor: 1.852

6.  Postoperative complications of combined phacoemulsification and pars plana vitrectomy in diabetic retinopathy patients.

Authors:  Assaf Gershoni; Edward Barayev; Doha Jbara; Amir Hadayer; Ruth Axer-Siegel; Assaf Dotan; Orly Gal-Or; Raimo Tuuminen; Rita Ehrlich
Journal:  Front Med (Lausanne)       Date:  2022-09-30

7.  Black patients sustain vision loss while White and South Asian patients gain vision following delamination or segmentation surgery for tractional complications associated with proliferative diabetic retinopathy.

Authors:  R Mastropasqua; Y H-L Luo; Y S Cheah; C Egan; J J Lewis; L da Cruz
Journal:  Eye (Lond)       Date:  2017-06-02       Impact factor: 3.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.